Bioethics News

Theranos Is Shutting Its Blood-Test Facilities, Shedding 40 Percent Of Workers

Theranos says it is shifting its focus to a product it calls the miniLab, with the goal of commercializing “miniaturized, automated laboratories.”

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.